NATCO Pharma Limited
Stock Forecast, Prediction & Price Target

NATCO Pharma Limited Financial Estimates

NATCO Pharma Limited Revenue Estimates

NATCO Pharma Limited EBITDA Estimates

NATCO Pharma Limited Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2021 3/31/2022 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
₹16.90B
 
N/A
₹19.04B
 
12.69%
₹40.02B
 
110.08%
Avg: ₹53.27B
Low: ₹53.27B
High: ₹53.27B
avg. 33.13%
Avg: ₹34.14B
Low: ₹34.14B
High: ₹34.14B
avg. -35.91%
Net Income
 
% change YoY
₹4.40B
 
N/A
₹1.7B
 
-61.44%
₹13.88B
 
716.64%
Avg: ₹18.22B
Low: ₹12.57B
High: ₹23.76B
avg. 31.30%
Avg: ₹6.47B
Low: ₹6.14B
High: ₹6.66B
avg. -64.47%
EBITDA
 
% change YoY
₹7.09B
 
N/A
₹3.34B
 
-52.94%
₹18.79B
 
462.72%
Avg: ₹18.76B
Low: ₹18.76B
High: ₹18.76B
avg. -0.18%
Avg: ₹12.02B
Low: ₹12.02B
High: ₹12.02B
avg. -35.91%
EPS
 
% change YoY
$24.2
 
N/A
$9.32
 
-61.48%
$77.34
 
729.82%
Avg: $101.7
Low: $70.2
High: $132.7
avg. 31.49%
Avg: $36.17
Low: $34.3
High: $37.2
avg. -64.43%
Operating Expenses
 
% change YoY
₹5.81B
 
N/A
₹10.81B
 
85.93%
₹31.16B
 
188.27%
Avg: ₹5.63B
Low: ₹5.63B
High: ₹5.63B
avg. -81.90%
Avg: ₹3.61B
Low: ₹3.61B
High: ₹3.61B
avg. -35.91%

FAQ

What is NATCO Pharma Limited stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -16.58% in 2026-2027.

We have gathered data from 11 analysts. Their low estimate is 12.57B, average is 18.22B and high is 23.76B.

What is NATCO Pharma Limited stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of -1.39% in 2026-2027.

We have gathered data from 12 analysts. Their low revenue estimate is ₹53.27B, average is ₹53.27B and high is ₹53.27B.

What is NATCO Pharma Limited stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of -16.47% in 2026-2027.

We have gathered data from 11 analysts. Their low earnings per share estimate is $70.2, average is $101.7 and high is ₹132.7.